“Clinical Consequences and Economic Burden Associated with Febrile Neutropenia in Hospitalized Cancer Patients: A Prospective Study”, J. Medicine, vol. 23, no. 1, pp. 48–53, Feb. 2022, doi: 10.3329/jom.v23i1.57937.